| Literature DB >> 36081817 |
Sara Maria Tamayo1, Tsu-Hsuan Wei2, Liang-Yu Chen3, Wen-Chao Ho4, Gil Ton1, Yu-Chen Lee1,2,3.
Abstract
Background: Major depressive disorder is identified as a mood disorder characterized by episodically recurring and potentially life-threatening negative symptoms. It is currently important for study, as it involves high morbidity, mortality and prevalence, as well as unsatisfactory treatment results. Aim: Establish an outpatient model from an integrative approach promoting the diversified development of traditional Chinese and Western medicine cooperation, leading to a holistic intervention for patients with depression. Experimental procedure: Fifteen participants with moderate to severe depression were followed up for eight weeks in the Acupuncture Department of the China Medical University Hospital in Taichung, Taiwan, under a collaborative outpatient model that combined Western psychiatry and traditional Chinese medicine (TCM). Interdisciplinary Intervention included manual acupuncture twice a week (16 sessions), tai chi, yoga meditation, and nutritional assessment. Symptomatology was measured with primary outcomes (self-reporting via questionnaires) and secondary outcomes (heart rate variability [HRV] and blood samples to measure inflammation via high-sensitivity C-reactive protein [hs-CRP]).Entities:
Keywords: Acupuncture; Body constitution, BC; CHR, Collaborative Healthcare Model; Collaborative care model; Major Depression Disorder, MDD; Major depressive disorder; Mind-body therapies; World Health Organization, WHO
Year: 2022 PMID: 36081817 PMCID: PMC9446101 DOI: 10.1016/j.jtcme.2022.03.002
Source DB: PubMed Journal: J Tradit Complement Med ISSN: 2225-4110
Fig. 18 weeks collaborative model Timeline.
Eight week long Collaborative healthcare model schedule, describing frequency of intervention. Acupuncture 2 times per week. Qi cong 1 time per week. Yoga and mindfulness once a month. Acupression and nutritional assessment at the beginning of the treatment.
| Collaborative model Schedule | ||||||||
|---|---|---|---|---|---|---|---|---|
| W1 | W2 | W3 | W4 | W5 | W6 | W7 | W8 | |
| Acupuncture | ●● | ●● | ●● | ●● | ●● | ●● | ●● | ●● |
| Nutritional assesment | ● | |||||||
| Acupressure | ● | |||||||
| Qi cong | ● | ● | ● | ● | ● | ● | ● | ● |
| Yoga | ● | ● | ||||||
| Mindfulness | ● | ● | ||||||
Possible groups of points for daily self-care massage set according to acupoint indications and body constitution (CCMQ).
| Acupression points for self-care massage | |
|---|---|
| Constitution | Acupression points |
| Qi deficiency | St36(Zusanli), Cv6 (Qi hai), Cv12 (Zhong guan) |
| Yin deficiency | Sp 6 (Sanyinyao), Kd 3(Taixi), Kd 7 (Fuliu) |
| Yang Deficiency | CV-4 (Guanyuan),St 36 (Zusanli),Cv12 (Zhong guan) |
| Heat-wetness | LV 11(qu chi), Bl 40 (weizhong), LI4 (Hegu) |
| Blood stagnation | GB 34 (Yanglingquan), Cv6 (Qi hai), Pc6 (Neiguan) |
| Phlegm | St 40 (felong), Pc5 (Jianshi), Sj 10 (Tianjing) |
| Qi stagnation | Liv 3 (Taichong), Li4 (Hegu), Cv6 (Qi hai) |
| Special diathesis | St36(Zusanli), LV 11(qu chi), Li 4 (Hegu) |
Patients with depression Baseline Characteristics N = 18, HAMD-21 Hamilton depression scale; BDI, Beck Depression Inventory scale; PSQI, Pittsburgh Sleep Quality Scale, QOLS, Quality of life scale.
| Patients with depression Baseline Characteristics N = 18 | |
|---|---|
| Characteristics | |
| Age (years, mean ± SD) | 40 ± 11.10 |
| Gender | |
| Male (n, %) | (5, 27.7%) |
| Female (n, %) | (13, 72.3%) |
| BMI Body Mass Index (kg/m2, mean ± SD) | 23.6 ± 4 |
| MDD history (years, mean ± SD) | 7.12 ± 8.54 |
| HAMD-21 (mean score ± SD) | 21 ± 5.1 |
| BDI-II (mean score ± SD) | 29 ± 9,6 |
| Pittsburgh (mean score ± SD) | 12.9 ± 3.7 |
| Qol (mean score ± SD) | 41.4 ± 6.9 |
| Main Constitution(CCMQ, mean score ± SD) | |
| Blood stagnation | (3, 16.6%) |
| Qi stagnation | (10, 55.5%) |
| Wetness heat | (1, 5.5%) |
| Qi deficiency | (2, 11.1%) |
| Phlegm-wetness | (1, 5.5%) |
| Gentleness | (2, 11.1%) |
| Taking only prescribed antidepressants (n, %) | (4, 20%) |
| Taking only prescribed TCM herbal medicine (n, %) | (2, 13.3%) |
| Taking combine TCM and antidepressants (n, %) | (12, 60%) |
Change in Symptom severity of MDD patients that before and after 8 weeks of treatment N = 15; HAMD-21 Hamilton depression scale; BDI, Beck Depression Inventory scale; PSQI, Pittsburgh Sleep Quality Scale, QOLS, Quality of life scale.
| Start of treatment period Mean (standard deviation) | ||||||
|---|---|---|---|---|---|---|
| Variable | Baseline | 8 weeks | 9 weeks | Difference | T value | P value |
| HAMD-21 | 19.5 (4.89) | 11.26 (5.77) | 11 (5.61) | 8.53 (6.06) | 5.45 | <0.001 |
| BDI | 28.46 (10.3) | 18.13 (12.3) | 18.13 (11.1) | 10.33 (10) | 3.99 | 0.0014 |
| PSQI | 12.1 (3.73) | 10.13 (3.99) | 10.13 (3.94) | 2.00 (3.6) | 2.11 | 0.0530 |
| QOLS | 42.97 (6.81) | 49.39 (9.4) | 48.935 (8.28) | −5.95 (5.39) | −4.28 | 0.0008 |
Fig. 2CCMQ constitutions means comparison at baseline and after treatment N = 15, Threshold 40 points. It was observed a significant mean change in Qi-deficiency 12.93 (17.6SD, p < 0.01); yin-deficiency 7.8 (10.46SD, p < 0.01); Wetness-heat 18.6 (22.05SD, p < 0.006); Blood-stasis 12.62 (19.7SD, p < 0.002); qi stagnation 19.73 (31.8SD p < 0.03). As well of a significant increase of Gentleness constitution 11,867 (13.9SD, p < 0.005).
Blood sample results comparison means before and after treatment in depressed patients N = 15. WBC (White blood cells) RBC (red blood cells) Hb (Hemoglobine), GOT (glutamic oxaloacetic transaminase) GPT (glutamic pyruvic transaminase) BUN (blood urea nitrogen), hsCRP (high-sensitivity C-reactive protein).
| Start of treatment period | |||||
|---|---|---|---|---|---|
| Variable | Baseline | 8 weeks | Difference | T value | P value |
| WBC u/l | 5.9733 (1.7746) | 5.7933 (1.4310) | 0.1800 (1.1845) | 0.59 | 0.5656 |
| RBC u/l | 4.6640 (0.4620) | 4.5853 (0.4047) | 0.0787 (0.2232) | 1.36 | 0.1938 |
| Hb g/dl | 13.9800 (1.2514) | 13.1533 (2.9377) | 0.8267 (2.7868) | 1.15 | 0.2699 |
| Platelet u/l | 237.8 (80.1779) | 254.1 (44.9388) | −16.2267 (64.7103) | −0.97 | 0.3479 |
| GOT u/l | 20.7333 (7.3335) | 20.7333 (11.9132) | 0 (8.9123) | 0 | 1 |
| GPT u/l | 24.4 (18.0665) | 22.9333 (21.7041) | 1.4667 (16.0395) | 0.35 | 0.7285 |
| BUN mg/dL | 14.9333 (3.7123) | 15.8 (3.9316) | −0.8667 (2.8752) | −1.17 | 0.2625 |
| Creatinine mg/dL | 0.7660 (0.1346) | 0.7827 (0.1496) | −0.0167 (0.0478) | −1.35 | 0.1980 |
| hsCRP mg/L | 0.1420 (0.1361) | 0.1153 (0.1474) | 0.0267 (0.0475) | 2.18 | 0.0472 |
Heart Rate before and after 8 weeks of treatment N = 15. HR, heart rate; SD standard deviation; VL, very low frequency; LF, low frequency; HF, High frequency.
| Start of treatment period | |||||
|---|---|---|---|---|---|
| Variable | Baseline | 8 weeks | Difference | T value | P value |
| HR (bpm) | 76.37 (13.22) | 75.6067 (8.54) | 0.7667 (12.23) | 0.24 | 0.8118 |
| SD ms2 | 32.14 (9.01) | 33.82 (16.71) | −1.6800 (16.95) | −0.38 | 0.7069 |
| VL ms2 | 5.88 (0.63) | 5.3867 (1.02) | 0.4933 (1.39) | 1.37 | 0.1936 |
| LF ms2 | 53.54 (15.19) | 50 (19.01) | 3.5400 (24.98) | 0.55 | 0.5918 |
| HF ms2 | 4.65 (1.108) | 7.24 (9.37) | −2.5867 (9.41) | −1.06 | 0.3054 |
Fig. 3Mechanism of action of multitarget integrated treatment for depressed patients: GI tract: gastrointestinal tract. CNS: central nervous system, BBB: blood brain barrier, HPA: Hypothalamus –pituitary – adrenal axis.